Evidence-based clinical practice guidelines for the management of psoriasis: systematic review, critical appraisal, and quality assessment with the AGREE II instrument

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Babiker Mohamed M.A.; El-Malky A.M.; Abdelkarim W.A.A.; Abdulmonem Salih Aabdeen M.; Hassan Elobid Ahmed T.; Sarsour H.H.H.; Mohammed Mosa M.; Amer Y.S.; Khormi A.A.M.; Alajlan A.

Journal: Journal of Dermatological Treatment

Publisher: Taylor and Francis Ltd.

Publication Date: 7 July 2022

Volume / Issue: Volume 33 / Issue 6

Pages: 2771–2781

ISSN: 9546634

DOI: 10.1080/09546634.2022.2083545

Scopus: View on Scopus

PubMed: 35737878

Document Type: Retracted


Authors and Affiliations

Babiker Mohamed M.A., Plastic and Reconstructive Surgery, Leeds University Teaching Hospital, Leeds, United Kingdom; El-Malky A.M., Public Health and Community Medicine Department, Theodor Bilharz Research Institute, Academy of Scientific Research, Ministry of Higher Education, Cairo, Egypt, Morbidity and Mortality Review Unit, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia; Abdelkarim W.A.A., Department of Obstetrics and Gynecology, King Saud University Medical City, Riyadh, Saudi Arabia; Abdulmonem Salih Aabdeen M., Pediatric Surgery Department, Pediatric Urology Division, Leeds University Teaching Hospital, Leeds, United Kingdom; Hassan Elobid Ahmed T., Trauma and Orthopedic Department, Manchester Royal Infirmary Hospital, Manchester, United Kingdom; Sarsour H.H.H., Mercy Corps Europe, Kadugli, Sudan; Mohammed Mosa M., College of Medicine, King Saud University, King Saud University Medical City, Riyadh, Saudi Arabia; Amer Y.S., Pediatric Department, King Khalid University Hospital, Riyadh, Saudi Arabia, Research Chair for Evidence-Based Health Care and Knowledge Translation, King Saud University, Riyadh, Saudi Arabia, Quality Management Department, Clinical Practice Guidelines and Quality Research Unit, King Saud University Medical City, Riyadh, Saudi Arabia, Alexandria Center for Evidence-Based Clinical Practice Guidelines, Alexandria University, Alexandria, Egypt, Adaptation Working Group, Guidelines International Network, Perth, United Kingdom; Khormi A.A.M., Internal Medicine and Rheumatology–Prince Sattam University Medical College, Al-Kharj, Saudi Arabia; Alajlan A., Dermatology Department, Faculty of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia


Abstract

Background: Psoriasis is considered one of the stubborn lifelong dermatologic diseases, making the patients seized in their social cage. Evidence-based clinical practice guidelines (CPGs) and expert opinions ensure that patients with psoriasis render the most recent and developed care. This systematic review assessed and compared the most recently approved international CPGs with the AGREE II instrument. Methods: After we identified our research question, we searched the bibliographic international databases to identify and screen for relevant and eligible guidelines that address the topic of interest. Four independent reviewers (Senior Expert Dermatologist in Psoriasis) have critically appraised the selected guidelines via the AGREE II instrument. We conducted inter-rater analysis and percent agreement among raters and calculation of intra-class correlation coefficient (ICC) ‘Kappa’. Results: Out of 33 articles for CPGs, only Four eligible CPGs fulfill the inclusion criteria. Selected CPGs were critically appraised; first from the American College of Rheumatology that is also National Psoriasis Foundation (ACR/NPF-2018), second from the UK’s National Institute for Health and Care Excellence (NICE-2017) for Psoriasis: Assessment and Management, third from the Saudi practical guidelines on the biologic treatment for Psoriasis (Saudi CPGs, 2015), and lastly from the American Academy of Dermatology (AAD/NPF-2019) Management and Treatment of Psoriasis with Awareness and Attention to Comorbidities. The complete assessments (OA) of two CPGs (AAD/NPF and NICE) scored greater than 80%; ‘six domains’ of AGREE II had greater score that is congruent with results; (1) scope and motive, (2) shareholder involvement, (3) rigor of growth, (4) clarity of speech, (5) validity, and (6) journalistic independence domains. Domain (3) scored (84, 71, and 90%), domain (5) (51%, 47, and 90%), domain (6) (70, 52, and 90%) for (Saudi CPGs, AAD/NPF, and NICE), respectively. Generally, the clinical recommendations were significantly better for NICE CPGs. Conclusions: Four evidence-based ‘CPGs’ introduced a high-quality methodological analysis. NICE indicated the greatest quality followed by Saudi CPGs and AAD/NPF and all four CPGs were suggested for practice. © 2022 Taylor & Francis Group, LLC.


Keywords

AGREE II instrument; critical appraisal; Practice guidelines; psoriasis; psoriatic arthritis; quality assessment; Humans; apremilast; biological product; biosimilar agent; calcineurin inhibitor; coal tar; cyclosporine; cytokine receptor antagonist; dimethyl fumarate; dithranol; emollient agent; etretin; interleukin 12; interleukin 17; interleukin 23; methotrexate; psoralen; steroid; vitamin D derivative; adolescent; adult; Appraisal of Guidelines for Research and Evaluation; body weight; cancer risk; clinical practice; drug utilization review; evidence based practice; human; inflammatory bowel disease; interrater reliability; phototherapy; practice guideline; quality assessment tool; quality control; Review; Saudi; stakeholder engagement; systematic review; ultraviolet A radiation; United Kingdom


Citation Information

Scopus Citations: 4


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer